Scientific Publication
07.03.2018
Keystone Symposia 2018, Banff (Canada) – LpD64 reduces intestinal dysbiosis associated with metabolic disorders
View
Scientific Publication
03.03.2018
Keystone Symposia 2018, Keystone (USA) – TOTUM-63 acts on intestinal microbiota
View
Scientific Publication
04.12.2017
International Diabetes Federation, 2017 Congress, Abu Dhabi (UAE) – TOTUM-63 reduces hepatic steatosis
View
Scientific Publication
06.06.2018
Cell Symposium 2017, San Diego (USA) – LpD64, in vivo effects on lipids metabolism
View
Scientific Publication
02.08.2017
American Diabetes Association, 2017 Congress, San Diego (USA) – VALEDIA®, results of the Phase I/II clinical study
View
Scientific Publication
16.03.2017
Société Francophone du Diabète, 2017 Congress, Lille (France) – TOTUM-63, preclinical data on insulin resistance and fat mass
View
Scientific Publication
10.06.2018
American Diabetes Association, 2016 Congress, New Orleans (USA) – TOTUM-63, preclinical data on glucose metabolism
View
Scientific Publication
10.03.2017
Keystone Symposia 2016, Keystone (USA) – LpD64, preclinical data on obesity
View